scispace - formally typeset
G

Gillian C. Barnett

Researcher at Cambridge University Hospitals NHS Foundation Trust

Publications -  48
Citations -  3477

Gillian C. Barnett is an academic researcher from Cambridge University Hospitals NHS Foundation Trust. The author has contributed to research in topics: Breast cancer & Radiogenomics. The author has an hindex of 27, co-authored 45 publications receiving 2951 citations. Previous affiliations of Gillian C. Barnett include University of Cambridge.

Papers
More filters
Journal ArticleDOI

Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.

TL;DR: There is interest in developing a test to measure an individual's radiosensitivity before treatment, and recent progress in genotyping raises the possibility of genome-wide studies to characterize genetic profiles that predict patient response to radiotherapy.
Journal ArticleDOI

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

TL;DR: It is hypothesised that partial-breast radiotherapy restricted to the vicinity of the original tumour in women at lower than average risk of local relapse will improve the balance of beneficial versus adverse effects compared with whole-breasts radiotherapy.
Journal ArticleDOI

Randomized Controlled Trial of Intensity-Modulated Radiotherapy for Early Breast Cancer: 5-Year Results Confirm Superior Overall Cosmesis

TL;DR: Improved dose homogeneity with simple IMRT translates into superior overall cosmesis and reduces the risk of skin telangiectasia, and should encourage centers still using two-dimensional RT to implement simple breast IMRT.
Journal ArticleDOI

Risk Factors for the Incidence of Breast Cancer: Do They Affect Survival From the Disease?

TL;DR: The finding that an increase in BMI is associated with a poorer prognosis supports previously published data and suggests that advice on weight loss should be given to all obese patients with breast cancer.